Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 3
2003 1
2006 2
2008 1
2009 2
2010 1
2012 3
2013 6
2014 3
2015 9
2016 3
2017 6
2018 10
2019 15
2020 12
2021 18
2022 20
2023 21
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Filler-Associated Vision Loss.
Tran AQ, Staropoli P, Rong AJ, Lee WW. Tran AQ, et al. Among authors: rong aj. Facial Plast Surg Clin North Am. 2019 Nov;27(4):557-564. doi: 10.1016/j.fsc.2019.07.010. Facial Plast Surg Clin North Am. 2019. PMID: 31587773 Review.
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham D, Jassem J, Rivera F, Kocákova I, Ruff P, Błasińska-Morawiec M, Šmakal M, Canon JL, Rother M, Williams R, Rong A, Wiezorek J, Sidhu R, Patterson SD. Douillard JY, et al. Among authors: rong a. N Engl J Med. 2013 Sep 12;369(11):1023-34. doi: 10.1056/NEJMoa1305275. N Engl J Med. 2013. PMID: 24024839 Free article. Clinical Trial.
Fedratinib-induced orbital inflammation.
Lee JY, Gallo RA, Vu DM, Anagnostopoulos AG, Rong AJ. Lee JY, et al. Among authors: rong aj. Orbit. 2022 Jun;41(3):346-349. doi: 10.1080/01676830.2020.1852263. Epub 2020 Nov 26. Orbit. 2022. PMID: 33243070 Review.
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt CJ, Strickland AH, Wilson G, Ciuleanu TE, Roman L, Van Cutsem E, Tzekova V, Collins S, Oliner KS, Rong A, Gansert J. Peeters M, et al. Among authors: rong a. J Clin Oncol. 2010 Nov 1;28(31):4706-13. doi: 10.1200/JCO.2009.27.6055. Epub 2010 Oct 4. J Clin Oncol. 2010. PMID: 20921462 Clinical Trial.
123 results